Here’s where I’m at on Meta right now. The stock traded at roughly $671 in late April when the Q1 report dropped. It’s since pulled back toward $577. That pullback happened despite Q1 revenue of $56.31 billion — up 33% year-over-year — and diluted EPS of $10.44, compared to $6.43 in Q1 2025. Daily active people across Meta’s Family of Apps hit 3.56 billion, a 4% gain.

So what spooked the market? The capex number. Meta raised its full-year 2026 capital expenditure guidance to a range of $125 billion to $145 billion, up from a prior range of $115 billion to $135 billion. Total expenses for the year are guided at $162 billion to $169 billion. The stock fell roughly 6% in after-hours trading on the announcement. The reaction is understandable — nearly doubling 2025’s $72.2 billion capex in a single year is a significant commitment that won’t be ignored.

But here’s the thing. Revenue is growing faster than that spending is expanding. And the Q2 guidance makes the next few weeks worth watching closely.

The Revenue vs. Spend Tension Is the Trade

Meta guided Q2 2026 total revenue to a range of $58 billion to $61 billion. Consensus 2026 full-year revenue is forecast at approximately $253 billion. The 2026 EPS estimate has been revised upward from $29.65 to $32.81. Free cash flow in Q1 came in at $12.4 billion with $81.18 billion in cash, cash equivalents, and marketable securities on the balance sheet — enough runway to absorb the spending increase without immediate solvency concerns.

Multi-year contractual commitments jumped by $107 billion in just Q1 alone. Cloud and infrastructure deals lock in compute capacity through 2027. Q1 capex alone hit $19.8 billion, the highest single-quarter figure in the company’s history.

What makes this interesting for active traders is not the spending — it’s whether the AI tools are actually generating ad revenue at a rate that justifies the spend. Advantage+ and full AI ad automation (enabling campaigns from a single image and budget) are expected to be live across the platform by end-2026. Analysts at Tickeron project these tools could boost advertiser ROI by 20-22%. That is the monetization number the market will be watching when Q2 results drop in late July.

Sector and Competitive Context

Slight tangent, but it matters: Alphabet and Amazon both reported Q1 earnings the same day as Meta and saw their stocks rise after hours. That divergence is telling. The market is not punishing AI capex categorically — it’s punishing AI capex that appears to be growing faster than the revenue it’s enabling. Meta’s job in Q2 is to demonstrate that the ad revenue flywheel is accelerating at a rate that closes that gap.

The digital advertising market is Meta’s core, representing the vast majority of revenue. That market cycles with GDP and consumer confidence but benefits structurally from AI-enhanced targeting. WhatsApp monetization is the emerging long-term option — analysts model it running from a $9 billion annualized rate today toward a $36 billion run-rate by 2029. Threads advertising is early but adds another surface. Both represent runway that doesn’t require capex to grow proportionally.

Meta also inked a deal with Crusoe to secure additional AI computing power as recently as June 18 — a sign the infrastructure buildout is ongoing and being addressed through multiple channels simultaneously. Separately, a China-related wrinkle emerged around the $2 billion Manus AI deal, with early backers reportedly exploring a reversal. That situation is worth monitoring as a sentiment variable even if the dollar amount is relatively small relative to Meta’s overall capex base.

Valuation Framework

At around $577, Meta is trading at a meaningful discount to the analyst consensus average price target of roughly $827. UBS carries a Buy target of $865. Jefferies sits at $910. The high target on the street is $1,015. The low is around $614. That range reflects genuine uncertainty about capex ROI timing — but consensus still leans strongly bullish.

On a forward earnings basis: applying a 23x multiple to the revised 2026 EPS estimate of $32.81 gets you to approximately $755. A 28-29x multiple — more consistent with the Magnificent Seven peer group average for faster-growing names — gets you toward $920-$950. The bear case multiple, if capex continues rising without visible ROI, compresses toward 18-19x, which implies downside toward $590-$625. The stock is currently trading inside that bear case range, which is either a warning or an opportunity depending on your view of Q2 execution.

Technical Structure

The pullback from $671 to the $577 area represents roughly a 14% correction from the post-earnings peak. The $600 zone is the first area of interest on any recovery attempt — it’s where the stock spent time before the Q1 report and where volume was concentrated. Above $620, the prior reaction highs come back into view. On the downside, $550 is the level to watch — a close below that level would suggest the post-Q1 correction is deeper than a simple capex-reaction trade and potentially signals something more structural.

Volume has been elevated on down days since the Q1 report, which is not ideal. But the macro backdrop matters: the S&P 500 is up approximately 24% over the past year and earnings growth across the index is projected at 19% annually. In that environment, a 33%-revenue-grower trading at a discount to its own five-year average multiple is worth watching closely.

Scenario Modeling

Bull Case: Q2 revenue comes in at or above the $61 billion high end of guidance. AI ad tools show measurable ROAS (return on ad spend) improvement. Management signals the capex range is stabilizing. Stock recovers toward $700-$750. UBS and Jefferies targets of $865-$910 become conversation-worthy. Catalyst: late-July Q2 earnings report.

Base Case: Q2 revenue lands near the midpoint of $58-$61 billion guidance. Capex commentary stays elevated but no further upward revision. EPS tracks the revised $32.81 annual estimate. Stock range-trades between $580 and $680 into earnings. Market needs to see the AI monetization data improve before re-rating the multiple.

Bear Case: Q2 revenue disappoints or full-year expense guidance is revised higher again. Manus AI deal disruption creates a regulatory or geopolitical overhang. Capex continues rising without a clear monetization milestone. Stock tests $540-$550 support. Below $520, the 2026 bull thesis gets questioned at the institutional level.

Active Trader Strategy Framework

The Q2 earnings date in late July is the hard catalyst to position around (it has not been formally confirmed yet, but is widely estimated for Wednesday, July 29, 2026). Options volume in META has been elevated since the Q1 report and will likely stay elevated as July approaches. Implied volatility into the print will be a key input for anyone considering defined-risk structures.

For traders thinking about directional positioning: the $600 level is the first key recovery test. If Meta can reclaim and hold $600 on volume, the next move toward $640-$660 becomes the base-case target range pre-earnings. A failure to hold $577 on a closing basis reopens the $550 test.

The tension between enormous capex and a still-robust revenue engine is not going away before Q2. That tension is the trade. The market has already punished the stock once for the capex surprise. Whether Q2 proves the spending is working — or whether it raises more questions — is what late July will answer. Position accordingly, size for the uncertainty, and don’t confuse the story with the data.

For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.